Local Institution

Pyatigorsk, Stavropol Kray 357502

0 studies enrolling now · 2 studies all time

What they study most

High Risk Stage III Melanoma, Melanoma

Studies at this site

• Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma — Completed
• Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma — Completed